Lexaria (NASDAQ: LEXX) Using DehydraTECH(TM) to Address Antihypertension Drug Market

October 20, 2022 10:48:15
  • Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness
  • The antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and diagnostic agents
  • Valued at US $30.2 billion in 2021, the market is expected to grow at a CAGR of 3%, resulting in a value of US $40 billion by 2031
  • Lexaria’s patented DehydraTECH(TM) technology offers higher bioavailability of active pharmaceutical ingredients due to, in part, bypassing first-pass-liver processing, improving the speed of onset, and brain absorption

The American Heart Association (“AMA”) refers to high blood pressure, or hypertension, as a “silent killer.” Nearly half of American adults have hypertension but do not know it because there are no obvious symptoms correlating to the condition. However, research finds that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness.

A recent study conducted by the AMA has found that hypertension may be linked to significant bone loss. The bone quality in younger mice with hypertension was similar to the bones of older mice without hypertension present. The study suggests that the effects of hypertension on the bones may mimic…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
[email protected]

HempWire is part of the InvestorBrandNetwork.